Avoid Prostate Biopsies with More Accurate Screening
Standard prostate cancer screening involves a prostate exam and a blood test that aims to identify a prostate-specific antigen (PSA) biomarker. If a man’s PSA level is high, doctors recommend a prostate biopsy. But for every four men who undergo the procedure, only one will end up having aggressive prostate cancer.
Although prostate cancer is the second most common cancer among American men, treatment has resulted in a 99 percent average five-year survival rate for diagnosed individuals, according to the Centers for Disease Control and Prevention. However, some experts argue that survival rate could be even higher with screening that is less invasive than the current standard.
I am aiming to eliminate “unnecessary poking and prodding” with a more precise screening method called the 4Kscore test. The screening method, which was developed by OPKO Lab in Nashville, Tennessee, incorporates a panel of four biomarkers and other clinical information to provide a more accurate reading of how aggressive an individual’s prostate cancer may be. I recommend that men who have high PSA levels take this additional blood test before getting a biopsy. Here I discuss this new test with Manny Alverez at FoxNews.
The test is commercially available right now, and it’s been studied over many years at Memorial Sloan Kettering Cancer Center. Screening is recommended for men between 40 and 50, African Americans, and men who have a family history of prostate cancer have the highest risk of being diagnosed with prostate cancer.
If you think you would benefit from the 4Kscore test and others like it, please contact me.